Here, we define an endothelial cell (EC) lumen signaling complex involving Cdc42, Par6b, Par3, junction adhesion molecules (Jam)-B and -C, membrane-type 1-matrix metalloproteinase (MT1-MMP), and integrin, α2β1, which coassociate to control human EC tubulogenesis in 3D collagen matrices. Blockade of both Jam-B and Jam-C using antibodies, siRNA, or dominant negative mutants completely interferes with lumen and tube formation resulting from a lack of Cdc42 activation, inhibition of Cdc42-GTPdependent signal transduction, and blockade of MT1-MMP-dependent proteolysis. This process requires interdependent Cdc42 and MT1-MMP signaling which involves Par3 binding to the Jam-B and Jam-C cytoplasmic tails, an interaction that is necessary to physically couple the components of the lumen signaling complex. MT1-MMP proteolytic activity is necessary for Cdc42 activation during EC tube formation in 3D collagen matrices but not on 2D collagen surfaces while Cdc42 activation is necessary for MT1-MMP to create vascular guidance tunnels and tube networks in 3D matrices through proteolytic events. This work reveals a novel interdependent role for Cdc42-dependent signaling and MT1-MMP-dependent proteolysis, a process that selectively occurs in 3D collagen matrices and which requires EC lumen signaling complexes, to control human EC tubulogenesis during vascular morphogenesis.
Introduction
Recent work has lead to an increased understanding for how endothelial and epithelial cells make lumens and tubes in 3D extracellular matrices [1] [2] [3] [4] [5] [6] [7] [8] [9] . Key regulators of lumen formation include Cdc42 which was first shown to regulate this process in endothelial cells (ECs) [10] [11] [12] and later in epithelial cells 13, 14 . Components of the cell polarity machinery including Par3, Par6, and PKCζ control lumen formation of both cell types 6, 11, [13] [14] [15] . Furthermore, we recently reported that Cdc42 activates a signaling cascade involving PKCε, Pak2, Pak4, Src, Yes, B-Raf, C-Raf and Erk1/2 to control this process 12, 16 . In addition, EC-directed cell surface proteolytic events through membrane type 1-matrix metalloproteinase (MT1-MMP) 17, 18 , controls EC lumen and vascular guidance tunnel formation in 3D collagen matrices 19, 20 . A key question that has remained unresolved is how Cdc42-dependent signaling and MT1-MMP-dependent proteolysis are functionally coupled to regulate EC tube formation 2 .
4 activation regulates MT1-MMP activity demonstrating a critical interdependent role for these two molecules during EC tubulogenesis in 3D matrices.
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Materials and Methods

EC lumen and tube formation in 3D collagen matrices
Human umbilical vein ECs (HUVECs) were purchased from Lonza and cultured as described 16 . For vasculogenic assays, ECs were suspended as single cells or 10-15 cellcell aggregates (pre-aggregated for 3 hrs) within 3.75 mg/ml collagen type I matrices and allowed to undergo EC morphogenesis 16 .
Transfection of ECs with siRNAs
EC transfection with either siGENOME SMARTpool or Stealth Select RNAi siRNAs was carried out in growth media with 1% serum as described 16, 24 . Sequences of single siRNAs are shown in Supplemental Table 1 .
3D EC culture pull-down assays for components of the lumen signaling complex
EC lumen formation assays were established as described 16 . Cultures were lysed at the indicated time-points using cold detergent lysis buffer and incubated with S protein agarose beads as described 11, 16 . In separate experiments, supernatants were incubated with GST-PAK-PBD or GST-RhoA-PBD protein beads (in the absence or presence of 100 nM GDP) for 90 min at 4˚C to assess the degree of Cdc42 or RhoA activation 11, 16 .
The beads were washed four times with washing buffer. Bound active Cdc42 or RhoA proteins were detected by Western blots.
Results
Requirement for both Jam-B and Jam-C during EC lumen and tube formation in 3D collagen matrices Members of the Jam family of adhesion receptors are known to interact through their cytoplasmic domains with Par3 [25] [26] [27] [28] , a molecule that is required for EC lumen formation 11 . We examined if siRNA suppression of Jams would affect this process.
siRNA suppression of either Jams-B or -C but not Jam-A (using both Smartpool mixtures and separate single siRNAs) resulted in inhibition of EC lumen formation ( Fig. 1 ) and suppression of protein expression (Fig. 1C) . Of interest is that Jam-A siRNA increases EC lumen formation suggesting that Jam-A may be an inhibitor of this process. To address whether combinations of Jams might affect lumen formation, we utilized different combinations of Jam siRNAs. The combination of Jam-B and Jam-C siRNAs markedly blocked EC lumen and tube formation in a manner greater than either of the individual siRNAs (Fig. 1B) . In contrast, this did not occur when Jam-A siRNA was mixed with either Jam-B or Jam-C siRNA.
Rescue experiments were performed on siRNA-treated ECs utilizing adenoviruses expressing wild-type Jams-B, -C, and -A (Fig. 1D,E) . As shown in Figure 1D and E, inhibition of lumen formation by siRNA suppression of Jams-B and -C is rescued by increased expression of Jam-C or a combination of Jam-B and Jam-C expression. Jam-B alone, Jam-A alone or GFP virus control fails to rescue this phenotype. Interestingly, while Jam-A siRNA treatment increases EC lumen formation, increasing expression of Jam-A leads to decreased lumen formation in these ECs. Thus, our data show that Jams-B and -C control EC lumen formation, while Jam-A appears to be inhibitory. In this system, Jams-B and -C act prior to multicellular EC tube assembly and thus, their influence in these assays, which mimic vasculogenesis, is not related to a lack of intercellular cell-cell junctional contacts (Videos 1-3). Time-lapse movies are shown of siRNA-treated ECs for luciferase control (Video 1), Jams-B and -C (Video 2) and Jam-A (Video 3). siRNA suppression of Jams-B and -C leads to complete blockade of EC lumen and tube formation in 3D collagen matrices prior to EC-EC contacts and multicellular tube assembly.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From For comparison, we also demonstrate that siRNA suppression of Cdc42, MT1-MMP, Par3, and Par6b, markedly block this process (Suppl. Fig. 1A ) as we have previously reported 11, 16, 18, 19 . Western blot analysis of the expression of these genes over a 24 hr time course (Suppl. Fig. 1B) shows that Jam-B and Jam-C expression are upregulated while Jam-A expression is downregulated (Suppl. Fig. 1C ). MT1-MMP is strongly upregulated while the other genes show modest to no changes in expression compared to actin control.
Blocking antibodies to Jams-B and -C markedly interfere with EC lumen and tube formation from single or pre-aggregated ECs in 3D collagen matrices To further address the functional role of Jams-B and -C during this process, blocking antibodies to these molecules were utilized. Neutralizing antibodies directed to Jams-B and -C have a blocking influence individually but when combined they show dramatic blocking of EC lumen formation ( Fig. 2A,B ). For comparison, blocking antibodies directed to the α2 and β1 integrin subunits also interfere with EC lumen formation 29 while those directed to the integrin α5 subunit have no influence ( Fig. 2A,B ).
This experiment was also performed with pre-aggregated ECs which were suspended in 3D collagen matrices. These aggregates rapidly produce multicellular lumen structures (arrowheads) (Fig. 2D,E) , a process that is markedly blocked by the combination of Jam-B and Jam-C blocking antibodies. The α2β1 integrin is also required for lumen formation from aggregated cells (Fig. 2D,E) . Thus, Jams-B and -C are required for EC lumen and tube formation from ECs suspended as single cells or as multicellular aggregates.
A further approach to address the functional role of Jam proteins is to utilize recombinant soluble Jam proteins which have been reported to block various Jamdependent cellular events 30 . Soluble Jam-B or Jam-C had blocking effects while soluble Jam-A had no influence on EC lumen formation (Fig. 2C) . Combining soluble Jam-B
and Jam-C increased their blocking effects just like the influence of Jam-B and Jam-C siRNAs or blocking antibodies as shown above.
siRNA suppression of Jams-B and -C selectively blocks EC motility in 3D collagen matrices but not on 2D collagen substrates Since the EC lumen and tube formation process involves EC motility 2, 12 , we examined if Jams-B and -C affect motility during these events. Nuclear GFP-labeled ECs were treated with the indicated siRNAs and placed either in 3D collagen matrices or on 2D collagen-coated surfaces to assess motility over 24 hr. siRNA suppression of Jams-B and -C selectively interferes with motility in 3D collagen matrices, while Jam-A siRNA treatment does not (Suppl. Fig. 2 ). In contrast, neither Jams-B and -C nor Jam-A siRNA suppression affects EC motility on 2D collagen surfaces (Suppl. Fig. 2) . Similarly, siRNA suppression of Cdc42, MT1-MMP, Par3, Par6b and α2β1 integrin, leads to selective blockade of EC motility in 3D collagen matrices and not on 2D collagen coated surfaces. Since EC lumen and tube formation is a 3D-matrix specific process 31, 32 , it is of great interest that these molecules selectively affect EC behavior in 3D collagen matrices but not on 2D collagen surfaces.
The Jam-B and Jam-C cytoplasmic tails are required for EC lumen and tube formation and Cdc42 activation in 3D collagen matrices
To address the functional importance of the Jams-B and -C cytoplasmic domains during these events, we generated adenoviral vectors carrying full-length and cytoplasmic tail deleted versions of Jams-B and -C. In addition, we generated a Jam-C construct with the distal most 5 amino acids from the cytoplasmic domain deleted which eliminates a Par3 binding site 25, 26 . ECs were induced to express these constructs and compared to control GFP vector (Suppl. Fig. 1D ). Increased expression of full-length Jam-C leads to increased EC lumen formation compared to control while increased full-length Jam-B expression has no effect (Fig. 3A,B ) and increased expression of Jam-A blocks lumen formation. Increased expression of cytoplasmic domain-deleted Jam-B or Jam-C leads to complete blockade of EC lumen formation (Fig. 3A,B) . A similar phenotype was observed using the 5 amino acid deleted Jam-C construct which also strongly abrogates EC lumen formation events (Fig. 3A,B) showing that the Par3-binding site of Jam-C is required for this process.
A key regulatory step in the EC lumen and tube formation process is activation of the Rho GTPase, Cdc42 11 . To address whether Jams-B and -C affect Cdc42 activation in 3D collagen matrices, we used the same Jam constructs to address their influence on Cdc42 activation during EC lumen formation in 3D collagen matrices. Expression of the Jam-B and Jam-C cytoplasmic tail deleted constructs markedly block Cdc42 activation as assessed using EC lysates from 3D collagen matrix cultures at 16 hr (Fig. 3C ). Lysates were incubated with Pak beads to bind activated Cdc42-GTP from 3D cultures undergoing tube morphogenesis 11, 16 . Increased expression of Jam-A also blocks Cdc42 activation while the other constructs have no effect compared to control. Starting material lysates show equal levels of Cdc42 in all cases. Thus, the cytoplasmic tails of Jam-B and Jam-C are necessary for Cdc42 activation in 3D collagen matrices and this lack of activation directly correlates with the inability of these treated ECs to form lumens and tubes.
Jams-B and -C are required for downstream kinase signaling events necessary to form EC lumens and tubes in 3D collagen matrices
We recently reported that a kinase cascade downstream of Cdc42 activation is required for EC lumen formation in 3D collagen matrices 12 . siRNA suppression of Jams- and Jam-C siRNA knockdown compared to Jam-A knockdown and control.
Jams-B and -C as well as Cdc42 are required for MT1-MMP-dependent vascular guidance tunnel formation during EC lumenogenesis A fundamental step in EC lumen and tube formation is the creation of vascular guidance tunnels which are MT1-MMP-generated matrix conduits controlling tube assembly and remodeling 19, 20 . siRNA suppression of Jams-B and -C, Cdc42 and MT1-MMP, markedly block vascular guidance tunnel formation, while siRNAs to Jam-A and control luciferase did not (Fig. 4C,D ). This data shows that MT1-MMP-dependent lumen and vascular guidance tunnel formation directly involves Cdc42 as well as Jams-B and -C. We show above that Jam-B and Jam-C (using cytoplasmic domain deletion constructs) are required for Cdc42 activation during lumen formation in 3D collagen matrices ( Fig. 3C ).
To assess whether we could detect co-associated Jam or other proteins in these
Pak bead eluates along with Cdc42-GTP, we performed Western blot analysis.
Luciferase control culture eluates contained Jam-B and Jam-C, Par3, MT1-MMP and the α2β1 integrin along with Cdc42-GTP suggesting that these proteins, which control EC lumen and tube formation, are coassociated in a multicomponent complex ( 
MT1-MMP activity as well as the Jam-B and Jam-C cytoplasmic tails are required for
Cdc42 activation in 3D collagen matrices but not on 2D collagen surfaces
To address the apparent interdependent role of MT1-MMP and Cdc42 signaling during these events, we performed an experiment whereby ECs were seeded within 3D collagen matrices or on 2D collagen surfaces to determine if MT1-MMP activity influences the degree of Cdc42 activation. We show that MT1-MMP activity is only required for EC motility and lumen formation in 3D collagen matrices 18, 19 and does not affect EC migratory behavior on 2D collagen surfaces (Suppl. Fig. 2 ). siRNA suppression of Cdc42 as well as Jam-B and Jam-C show the same phenotype with a 3D matrix-specific effect (Suppl. Fig. 2 ). EC cultures were established in 3D collagen matrices or on 2D collagen surfaces in the presence or absence of GM6001, a broad spectrum MMP inhibitor that blocks MT1-MMP (Fig. 5A ). Lysates were prepared at 16
hr of culture to assess Cdc42 activation, which controls EC lumen formation, and RhoA activation, which does not control this process 2,10,11 . As shown in Fig. 5A , Cdc 42 activation is observed at higher levels in the 3D versus 2D cultures and strong association of Jam-C, MT1-MMP and the α2β1 integrin are detected in the Pak bead eluates. In the presence of GM6001, there is a strong decrease in Cdc42 activation (and markedly decreased capture of Jam-C, MT1-MMP and α2β1 integrin) which selectively occurs in the 3D cultures but not the 2D cultures, an effect mimicked by siRNA suppression of MT1-MMP (Fig. 4E ). This does not occur when RhoA activation is assessed. There is increased RhoA activation in 3D versus 2D culture but there is no influence of GM6001
addition. This data strongly suggests that MT1-MMP activity controls Cdc42 activation and vice-versa in 3D collagen matrices revealing a critical interdependent signaling role for these molecules during these events.
As we show above, the Jam-B and Jam-C cytoplasmic tails are necessary for both EC lumen formation and Cdc42 activation (see Fig. 3 ). To address if this effect occurred selectively in 3D collagen matrices, we directly compared the influence of wild-type and Jam mutant expression in ECs that were either seeded on 2D collagen surfaces or within 3D collagen matrices (Fig. 5C ). After 16 hr of culture, lysates were prepared and Cdc42 activation was assessed. Expression of cytoplasmic tail-deleted Jam-B and Jam-C blocks Cdc42 activation selectively in 3D collagen matrices but not on 2D collagen surfaces compared to control conditions (Fig. 5C ), while these constructs have no influence on RhoA activation in either case.
To further address the role of MT1-MMP activity in Cdc42 activation within 3D collagen matrices, we expressed wild-type or catalytically dead (EA mutant) MT1-MMP full-length constructs 19 as well as cytoplasmic domain deletion mutants and performed EC lumen formation and Cdc42 activation assays. Each of the constructs also contains a C-terminal S-tag which allows the recombinant protein to bind S-agarose beads from lysates ( Fig. 5B ). As shown in Fig. 6A , a time-lapse movie analysis of EC lumen formation over 24 hr reveals that expression of full-length wild-type MT1-MMP increases the rate of lumen formation while expression of the cytoplasmic domaindeleted wild-type construct markedly increases this rate. We analyzed surface expression of MT1-MMP under these conditions by immunostaining (2D vs. 3D) and immunoprecipition of biotinylated surface proteins (Suppl. Fig. 3 ). The wild-type cytoplasmic domain-delected construct shows increased cell surface expression compared to the wild-type full length construct which accounts in part for the increased lumen formation observed. The EA mutant full-length construct does not enhance formation
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From compared to control GFP while the EA mutant cytoplasmic tail-deleted construct strongly inhibits EC lumen and tube formation (Fig. 6B ). This latter mutant shows dominant negative functions in blocking lumen formation. Each of these constructs are expressed as they bind S-protein agarose beads from lysates obtained from 3D cultures at 16 hr (Fig. 5C) . These results were confirmed by assessing vascular guidance tunnel formation where increasing wild-type MT1-MMP expression increases tunnel formation which was further increased using the wild-type cytoplasmic tail-deleted construct (Fig. 6B) . In contrast the EA mutant, cytoplasmic tail-deleted construct blocked vascular guidance tunnel formation consistent with its ability to block EC lumen formation and to serve as a dominant negative MT1-MMP mutant.
Lysates prepared from the 3D cultures were incubated with either Pak beads to assess the degree of Cdc42 activation or separately with S-protein beads to assess the association of Cdc42, Jam-C, or α2β1 with the different MT1-MMP constructs (Fig. 6C) .
Expression of the dominant negative MT1-MMP construct shows no lumen or vascular guidance tunnel formation and importantly, blocks Cdc42 activation compared to the other MT1-MMP constructs. This result provides additional key evidence that MT1-MMP activity is required for Cdc42 activation in 3D collagen matrices to coordinate EC lumen formation. Also, the dominant negative MT1-MMP mutant does not associate with Cdc42, Jam-C or α2β1 in contrast to the other constructs, where clear binding of these molecules is demonstrated. The binding of these associated molecules to S-protein beads depends on the S-tag as MT1-MMP constructs without this tag do not show these associations (Fig. 5B) . Increasing MT1-MMP activity using the wild type cytoplasmic tail deleted mutant reveals an even greater degree of association of MT1-MMP with α2β1, Jam-C and Cdc42 (Fig. 6C) which correlates with increased lumen and vascular guidance tunnel formation (Fig. 6A,B) . Also, this result demonstrates that the cytoplasmic tail of MT1-MMP is not required for its association with this lumen signaling complex of proteins.
Jams-B and -C coordinate a lumen signaling complex involving Cdc42, Par6b, Par3, MT1-MMP and the α2β1 integrin to control EC lumen and tube formation in 3D
org From
To address how Jams-B and -C control EC lumen and tube formation, we have performed experiments to assess whether these adhesion receptors are critical regulatory components of a multimolecular lumen signaling complex. As shown above, Cdc42, Jams-B and -C, MT1-MMP, and α2β1 coassociate in complexes which directly correlate with the ability of ECs to form lumens and tubes (see Figs. 4E and 5A ). S-tagged versions of Cdc42, MT1-MMP and Jam B are able to bind each of the key components of the lumen signaling complex including Cdc42, Par3, Par6b, Jam-B, Jam-C, MT1-MMP and α2β1 using lysates prepared from 3D collagen matrix cultures at 16 hr (Fig. 5B) . We do not observe binding of Jam-A, RhoA, or the α5β1 integrin within this complex (Fig.   5B ). Previous work showed that MT1-MMP was found to be associated with the hyaluronate receptor, CD44 33 and we confirm this interaction (Fig. 5B ). These associations are only observed using the S-tagged recombinant proteins and not with expressed untagged protein using S-agarose beads (Fig. 5B ).
To further address the specificity of these binding experiments, they were showing that MT1-MMP and Jam-C are co-localized in ECs with lumens as assessed by staining non-permeabilized ECs in 3D collagen matrices (Suppl. Fig. 5 ).
An additional series of experiments was performed to elucidate how this complex is organized to control EC lumen and tube formation. We combined siRNA suppression with expression of recombinant S-tagged Cdc42, Jam-B, and MT1-MMP or control GFP virus to identify how the lumen signaling complex is organized. Jam-B and Jam-C siRNA suppression compared to control luciferase allows for the binding of the expressed S-tagged constructs to S-agarose beads as expected, but no binding of Jam-C, MT1-MMP or α2β1 integrin to S-GFP-Cdc42 (Fig. 7A) . Similarly, Jam-B and Jam-C knockdown eliminates the coassociation of MT1-MMP-S to endogenous Cdc42, but does not affect its binding to α2β1. There is no binding of these molecules to S-agarose beads when control GFP virus is used. siRNA suppression of Par3 eliminates the binding of Jam C, MT1-MMP and α2β1 integrin to S-GFP-Cdc42 but has no influence on the interaction of these molecules to MT1-MMP-S showing that Par3 is proximal to Cdc42 in this multiprotein complex. siRNA suppression of MT1-MMP eliminated the ability of S-GFP-Cdc42 to associate with either Jam-C or α2β1 integrin which provides further support for the concept that MT1-MMP activity is necessary for Cdc42 activation and its ability to couple to this complex (Fig. 7B) . Additional experiments utilized Jam-B-S tag to investigate its associations during the lumen formation process. As shown in integrin. This data suggests that MT1-MMP and the α2β1 integrin appear functionally interdependent and siRNA suppression of either molecule does not allow for coupling of either of these two molecules with Jam-C. In support of this conclusion, siRNA suppression of Jam-C completely eliminates the association of Jam-B with MT1-MMP and α2β1 integrin (Fig. 7C) suggesting that Jam-C is coupled to this proteinase/integrin For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From complex and is in between Jam-B and this complex. Also, siRNA suppression of Par3 disconnects Cdc42 from the Jam-B-S-tag, but does not affect Jam-B's association with Jam-C, MT1-MMP or α2β1 integrin (Fig. 7D) . This further supports the idea that Jam-C interacts with MT1-MMP and α2β1 complexes. A schematic diagram illustrating the organization of the EC lumen signaling complex is shown in Fig. 7E . This EC lumen signaling complex which contains Jams-B and -C, coordinates integrin signaling, MT1-MMP proteolytic events, and Cdc42-GTP-dependent signaling events to control vascular tube morphogenesis in 3D collagen matrices.
Discussion
In this work, we present the novel concept that a lumen signaling complex exists controlling the ability of ECs to form tubular networks in 3D collagen matrices. This complex of proteins consists of Cdc42, Par6b, Par3, Jam-B, Jam-C, MT1-MMP and the α2β1 integrin and together they control the lumen and tube formation process by coordinating integrin recognition and localized MT1-MMP-dependent degradation of collagen matrix with Cdc42 activation-dependent signaling necessary for EC tube and network formation (Fig. 7E) . This complex stimulates a 3D matrix-specific lumen formation process in collagen matrices which reveals a fundamental interdependent role for Cdc42-and MT1-MMP-dependent signaling during these events. MT1-MMP activity is required for Cdc42 activation in 3D collagen matrices but not on 2D collagen surfaces, while Cdc42 is required for MT1-MMP-dependent proteolytic events in 3D matrices, a necessary step for lumen and coincident vascular guidance tunnel formation.
Jams-B and -C control EC lumen and tube formation in 3D collagen matrices
We report the novel observation that Jams-B and -C are critical regulators of EC lumen and tube formation in 3D collagen matrices. Previous work with Jam proteins suggest that they are primary regulators of tight junctional contacts and coordinate polarity signaling through interactions with Par3 and their cytoplasmic tails 25, 34 . Each of the Jams, Jam-A, Jam-B and Jam-C can bind Par3 through a binding site on the Cterminus of the tail. The ability of Par3 to bind Par6 allows for coupling of these receptors to Cdc42, a key GTPase known to affect cell polarization events including apical-basal polarity and directed cell motility 35, 36 . Importantly, we first reported that Cdc42 controlled lumen formation of ECs in 3D matrices 10 . Our work and that of others has shown that Par3 is involved in lumen formation of both endothelial cells and epithelial cells in 3D matrices 10, 13 . A key distinction in our systems versus the epithelial cell models is that the blocking influence of Par3 can be observed prior to multicellular tube assembly. During vasculogenesis, individual ECs interconnect through sprouting and early lumen formation events 1,9,37 , such as intracellular vacuolation, to assemble into multicellular tube networks. Knockdown of Par3 or Par6b, markedly blocks the ability of ECs to undergo these critical early events that are necessary to reach their neighbors and assemble into multicellular tube networks 11 . Our results reveal the same phenomenon with blockade of Jam-B and Jam-C. However, it is likely that the Jams as well as Par3
and Par6 proteins also play a role in the process of EC multicellular tube assembly in order for ECs to be properly spatially organized within a tube structure. There is precedent for our results with single ECs in that Jam-A knockout neutrophils are unable to directionally migrate as single cells in response to chemotactic cues 38, 39 . To address the issue of multicellular tube assembly, we showed that blocking antibodies to Jams-B and -C markedly block lumen formation from either single ECs or pre-aggregated ECs in 3D collagen matrices (Fig. 2) , suggesting that the signaling mechanisms controlling lumen formation under these different conditions appear similar.
There is prior work revealing a role for Jam-C in angiogenic responses in that Jam-C blocking antibodies, when administered to mice, were able to interfere with angiogenesis 40 . The mechanisms underlying the influence of these antibodies were unclear. Our studies here show a direct role for both EC Jam-B and Jam-C in controlling human EC tubular morphogenesis in 3D collagen matrices. The systems used here have previously identified critical regulators of EC lumen and tube formation 1, [10] [11] [12] [18] [19] [20] 29, 31, 32, 41 that have been demonstrated to be relevant during vessel morphogenesis in vivo. This includes the identification of MT1-MMP as a critical regulator of angiogenesis in adult mice 17, 42 , the identification of Pak4, a Cdc42-specific effector, and Rac1 as both required for developmental vascularization 43, 44 , the finding that Src, Pak, and Raf regulate angiogenesis 45 , the identification of CCM2, as a regulator of early aortic arch lumen development and EC lumen formation in vitro 46 , and an important role for α2β1, β1
integrins, and Par3 during developmental and adult vascularization events 15, 47, 48 .
Lumen signaling complexes involving Cdc42, Par3, Jam-B and Jam-C, and MT1-MMP control EC tubulogenesis in a 3D matrix-specific manner
In this study, we present data showing that a lumen signaling complex exists in ECs to control the 3D matrix-specific process of EC lumen and tube formation. We make the novel observation that Cdc42 activation is controlled by MT1-MMP proteolytic activity in 3D collagen matrices but not on 2D collagen matrix surfaces. The coupling of MT1-MMP to Cdc42 activation and signaling through the lumen signaling complex provides an explanation for why MT1-MMP is so critical for EC tubulogenesis in 3D collagen matrices. Also, Cdc42 activation is necessary for MT1-MMP to proteolyze cultures were established in 3D collagen matrices. After 16 hr, detergent lysates were prepared and incubated with GST-PAK-PBD beads as described 16 . Eluates were analyzed for Cdc42 activation since these beads only bind Cdc42-GTP. Western blots were probed with antibodies to the indicated components of the lumen signaling complex. Starting material was probed for total Cdc42 which was equivalent in all cases. matrices. After 16 hr, detergent lysates were prepared and incubated with S proteinagarose beads as described 16 to assess whether the indicated components of the lumen signaling complex could be found to be coassociated with MT1-MMP. In addition, the lysates were incubated with GST-PAK-PBD beads to assess the degree of Cdc42 activation. In each case, the starting material lysates were examined for total Cdc42 levels. For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From
